Loading organizations...
Based in Haifa, Israel, Embryonics develops artificial intelligence software that analyzes embryo videos and patient medical data to improve in vitro fertilization selection processes for fertility clinics. The company's proprietary algorithm is designed to increase positive predictive value by 12 percent and negative predictive value by 29 percent compared to traditional manual embryologist assessments. Operating with a team of approximately 16 employees, the enterprise has raised $4 million in seed funding backed by lead investors including the Shustermann Family Investment Office and the Israeli Innovation Authority. The firm provides its diagnostic technology to the broader fertility sector and has established clinical partnerships with medical institutions such as Jaslok Hospital, while its leadership team draws on prior technical experience from Apple and Intel. Embryonics was founded in 2018 by Yael Gold-Zamir, David Silver, and Alex Bronstein.
Embryonics has raised $4.0M across 1 funding round.
Embryonics has raised $4.0M in total across 1 funding round.
Embryonics has raised $4.0M in total across 1 funding round.
Embryonics's investors include Israeli Innovation Authority, Schusterman Family Investments.
Embryonics has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in January 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 20, 2021 | $4M Seed | Israeli Innovation Authority, Schusterman Family Investments | — | Announced |
